Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
57.50
-0.60 (-1.03%)
At close: Apr 13, 2026
-2.38% (1Y)
| Market Cap | 6.18B +11.2% |
| Revenue (ttm) | 10.07B +26.3% |
| Net Income | 609.04M +44.4% |
| EPS | 5.65 +43.8% |
| Shares Out | 107.42M |
| PE Ratio | 10.18 |
| Forward PE | n/a |
| Dividend | 1.40 (2.43%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 264,085 |
| Average Volume | 303,790 |
| Open | 58.20 |
| Previous Close | 58.10 |
| Day's Range | 57.20 - 58.70 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | 0.08 |
| RSI | 48.58 |
| Earnings Date | Jan 28, 2026 |